Rare Kidney Stone Consortium Biobank
Learn more about:
Related Clinical Trial
Nedosiran in Pediatric Patients From Birth to 5 Years of Age With PH and Relatively Intact Renal Function
Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD
Rare Kidney Stone Consortium Biobank
Long Term Extension Study in Patients With Primary Hyperoxaluria
International Registry for Primary Hyperoxaluria
A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2